Safety and Efficacy Study of Novel Gene Therapy ZM-02 for Retinitis Pigmentosa Patients (clinicaltrials.gov) - Aug 15, 2024 - P1 | N=12 | Recruiting | Sponsor: Zhongmou Therapeutics | Not yet recruiting ➔ Recruiting
Enrollment open • Gene therapy • Gene Therapies • Genetic Disorders • Inherited Retinal Dystrophy • Ocular Inflammation • Ophthalmology • Retinal Disorders • Retinitis Pigmentosa
|